Golden Hour Treatment With tPA (Tissue-Type Plasminogen Activator) in the BEST-MSU Study.
Jason MackeyJose-Miguel YamalStephanie A ParkerKelly SilnesSuja S RajanAsha P JacobMengxi WangNoopur SinghWilliam J JonesIlana SpokoynyBabak Benjamin NaviJeffrey L SaverJames Charles Grottanull nullPublished in: Stroke (2023)
FHT almost doubles the odds of excellent clinical outcome without increased risk compared with later treatment, which supports the use of MSUs.
Keyphrases